Safety and feasibility of percutaneous autologous skeletal myoblast transplantation in the coil-infarcted swine myocardium. (Q51820418)

13 April 2018

title

Safety and feasibility of percutaneous autologous skeletal myoblast transplantation in the coil-infarcted swine myocardium. (English)

1 reference

13 April 2018

0 references

Nabil Dib

1

1 reference

13 April 2018

Ann Campbell

2

1 reference

13 April 2018

Douglas B Jacoby

3

1 reference

13 April 2018

Agatha Zawadzka

4

1 reference

13 April 2018

Judson Ratliff

5

1 reference

13 April 2018

Brigitte M Miedzybrocki

6

1 reference

13 April 2018

Amir Gahremanpour

7

1 reference

13 April 2018

Edward B Diethrich

8

1 reference

13 April 2018

Shaun R Opie

9

1 reference

13 April 2018

publication date

3 February 2006

1 reference

13 April 2018

Journal of Pharmacological and Toxicological Methods

published in

1 reference

13 April 2018

volume

54

1 reference

13 April 2018

issue

1

1 reference

13 April 2018

page(s)

71-77

1 reference

13 April 2018

Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Cellular cardiomyoplasty improves diastolic properties of injured heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Validation of thoracic electrical bioimpedance as a porcine research tool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Electroanatomic left ventricular mapping in the porcine model of healed anterior myocardial infarction. Correlation with intracardiac echocardiography and pathological analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Endoventricular porcine autologous myoblast transplantation can be successfully achieved with minor mechanical cell damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Incomplete retention after direct myocardial injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Cell transplantation for myocardial repair: an experimental approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Myoblast transplantation for heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Skeletal myoblast transplantation for repair of myocardial necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Technical delivery of myogenic cells through an endocardial injection catheter for myocardial cell implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Factors affecting functional outcome after autologous skeletal myoblast transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.12.002

10.1016/J.VASCN.2005.12.002

7 January 2021

Identifiers

DOI

1 reference

13 April 2018

PubMed ID

16458541

1 reference

13 April 2018